SCHEMBL20062810

SCHEMBL20062810

c1ccc2c(c1)c1ccccc1c1cc3c(cc21)-c1cc(-n2c4ccccc4c4ccccc42)c(-n2c4ccccc4c4ccccc42)cc1-c1cc2c4ccccc4c4ccccc4c2cc1-c1cc(-n2c4ccccc4c4ccccc42)c(-n2c4ccccc4c4ccccc42)cc1-3

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ATM Q13315 1/20 0.46
ALDH1A1 P00352 3/20 0.44
GPR3 P46089 1/20 0.39
CYP1A2 P05177 2/20 0.38
CYP2C19 P33261 2/20 0.38
POLB P06746 1/20 0.38
CYP2C9 P11712 1/20 0.34
DUSP3 P51452 1/20 0.34
CYP19A1 P11511 1/20 0.33
BACE1 P56817 2/20 0.32
MAPT P10636 3/20 0.32
HTT P42858 3/20 0.32
LMNA P02545 2/20 0.32
MEN1 O00255 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
HSD17B10 Q99714 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20062675 0.96 L3MBTL1 (0.43) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL30451338 0.89 L3MBTL1 (0.48) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL25223924 0.89 L3MBTL1 (0.48) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL17915754 0.86 KDM4E (0.54) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL20062803 0.85 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1DUSP3
SCHEMBL12258331 0.84 KDM4E (0.56) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL13775289 0.82 KDM4E (0.50) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL20062832 0.81 ALDH1A1 (0.41) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL20062667 0.81 ALDH1A1 (0.41) KDM4EL3MBTL1ATMALDH1A1GPR3
SCHEMBL20062652 0.80 ALDH1A1 (0.40) KDM4EL3MBTL1ATMALDH1A1GPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608185-B2 Organic electroluminescent materials and devices UNIVERAL DISPLAY CORPORATION (US) 2020-03-31 US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108844-A1 Organic Electroluminescent Materials and Devices SLCO4C1, SLCO2A1, SLCO2B1 KDM4E 4299/4885L3MBTL1 2321/4885ATM 4318/4885
US-10608185-B2 Organic electroluminescent materials and devices SLCO4C1, SLCO2A1, SLCO2B1 KDM4E 4299/4885L3MBTL1 2321/4885ATM 4318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.